EXCEDRIN (MIGRAINE RELIEF) Drug Patent Profile
✉ Email this page to a colleague
When do Excedrin (migraine Relief) patents expire, and when can generic versions of Excedrin (migraine Relief) launch?
Excedrin (migraine Relief) is a drug marketed by Haleon Us Holdings and is included in one NDA.
The generic ingredient in EXCEDRIN (MIGRAINE RELIEF) is acetaminophen; aspirin; caffeine. There are sixty-six drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the acetaminophen; aspirin; caffeine profile page.
Summary for EXCEDRIN (MIGRAINE RELIEF)
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 3 |
Clinical Trials: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | EXCEDRIN (MIGRAINE RELIEF) at DailyMed |
US Patents and Regulatory Information for EXCEDRIN (MIGRAINE RELIEF)
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Haleon Us Holdings | EXCEDRIN (MIGRAINE RELIEF) | acetaminophen; aspirin; caffeine | TABLET;ORAL | 020802-001 | Jan 14, 1998 | OTC | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for EXCEDRIN (MIGRAINE RELIEF)
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Haleon Us Holdings | EXCEDRIN (MIGRAINE RELIEF) | acetaminophen; aspirin; caffeine | TABLET;ORAL | 020802-001 | Jan 14, 1998 | ⤷ Try a Trial | ⤷ Try a Trial |
Haleon Us Holdings | EXCEDRIN (MIGRAINE RELIEF) | acetaminophen; aspirin; caffeine | TABLET;ORAL | 020802-001 | Jan 14, 1998 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for EXCEDRIN (MIGRAINE RELIEF)
See the table below for patents covering EXCEDRIN (MIGRAINE RELIEF) around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Australia | 8170598 | ⤷ Try a Trial | |
Argentina | 016337 | USO DE UNA COMBINACION DE N-(4-HIDROXIFENIL)ACETAMIDA (ACETOAMINOFENOL,APAP); ACIDO 2-(ACETILOXI)BENZOICO (ASPIRINA ASA) Y 3,7-DIHIDRO-1, 3, 7-TRIMETIL-1H-PURINA-2,6-DIONA (CAFEINA, CAF) Y COMPOSICION FARMACEUTICA QUE COMPRENDE DICHA COMBINACION | ⤷ Try a Trial |
Spain | 2198725 | ⤷ Try a Trial | |
Austria | 240105 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |